HomeInsightsStock Comparison

Bharat Parenterals Ltd vs Sms Pharmaceuticals Ltd Stock Comparison

Bharat Parenterals Ltd vs Sms Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jun 04, 2025

Key Highlights

  • The Latest Trading Price of Bharat Parenterals Ltd is ₹ 1294 as of 04 Jun 15:30.
  • The P/E Ratio of Bharat Parenterals Ltd changed from 3.4 on March 2020 to 45 on March 2024 . This represents a CAGR of 67.63% over 5 yearsThe P/E Ratio of SMS Pharmaceuticals Ltd changed from 7.1 on March 2020 to 30.2 on March 2024 . This represents a CAGR of 33.58% over 5 years.
  • The Market Cap of Bharat Parenterals Ltd changed from ₹ 81.25 crore on March 2020 to ₹ 648.03 crore on March 2024 . This represents a CAGR of 51.48% over 5 yearsThe Market Cap of SMS Pharmaceuticals Ltd changed from ₹ 225.6 crore on March 2020 to ₹ 1507 crore on March 2024 . This represents a CAGR of 46.21% over 5 years.
  • The revenue of Bharat Parenterals Ltd for the Mar '25 is ₹ 105.91 crore as compare to the Dec '24 revenue of ₹ 75.2 crore. This represent the growth of 40.84% The revenue of SMS Pharmaceuticals Ltd for the Mar '25 is ₹ 249.62 crore as compare to the Dec '24 revenue of ₹ 175.48 crore. This represent the growth of 42.25%.
  • The ebitda of Bharat Parenterals Ltd for the Mar '25 is ₹ 4.16 crore as compare to the Dec '24 ebitda of ₹ 6.59 crore. This represent the decline of -36.87% The ebitda of SMS Pharmaceuticals Ltd for the Mar '25 is ₹ 42.23 crore as compare to the Dec '24 ebitda of ₹ 35.34 crore. This represent the growth of 19.5%.
  • The net profit of Bharat Parenterals Ltd changed from ₹ 7.01 crore to ₹ -9.44 crore over 8 quarters. This represents a CAGR of NaN% The net profit of SMS Pharmaceuticals Ltd changed from ₹ 8.81 crore to ₹ 20.08 crore over 8 quarters. This represents a CAGR of 50.97% .
  • The Dividend Payout of Bharat Parenterals Ltd changed from 1.78 % on March 2023 to 2.58 % on March 2024 . This represents a CAGR of 20.39% over 2 yearsThe Dividend Payout of SMS Pharmaceuticals Ltd changed from 6.48 % on March 2020 to 6.86 % on March 2024 . This represents a CAGR of 1.15% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Bharat Parenterals Ltd

  • Bharat Parenterals Ltd. was incorporated on Sep.'92 in Gujarat and promoted by Ramesh Desai and Bharat Desai.
  • The Company is engaged in the business of manufacturing drugs, pharmaceutical formulations and ayurvedic products at its plant in Baroda.
  • It has set-up a fully integrated and modern plant as per WHO standards at Haripura near Baroda for manufacturing pharmaceutical formulations, life saving drugs, parenterals and antibiotics. In 2016, Varenyam Healthcare Private Limited was incorporated as wholly owned subsidiary company effective 09 July, 2016.
  • Innoxel Lifesciences was incorporated as wholly owned subsidiary company effective 16th October, 2020.
  • Varenyam Biolifesciences got incorporated as wholly owned subsidiary company effective 28th June, 2022.

About SMS Pharmaceuticals Ltd

  • SMS Pharmaceuticals Limited was incorporated in December, 1987.
  • The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates.
  • Apart from R &D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa Village in Vijayanagaram District of Andhra Pradesh.
  • Its business activity is a single primary business segment of 'Bulk Drugs'. During the year 2015, the company has re-enforced its fundamental strength of FDA compliant facilities by successfully completing the US FDA audits at Kandivalasa and Bachupally facilities. During the year 2015, the company filed 9 Drug Master Files and total DMFs filed up to 31 March 2015 are 24. During the year 2014-15, the Company acquired 12,25,900 equity shares of Rs.

Bharat Parenterals Ltd News Hub

News

Board of Bharat Parenterals recommends Final Dividend

Bharat Parenterals announced that the Board of Directors of the Company at its meeting hel...

Read more

12 May 2025 17:16

News

Bharat Parenterals to convene board meeting

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 12 May ...

Read more

06 May 2025 11:30

News

Bharat Parenterals to announce Quarterly Result

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 3 Febru...

Read more

24 Jan 2025 10:28

News

Bharat Parenterals to announce Quarterly Result

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 29 Octo...

Read more

21 Oct 2024 10:22

News

Bharat Parenterals announces board meeting date

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 8 Augus...

Read more

01 Aug 2024 10:54

News

Bharat Parenterals schedules AGM

Bharat Parenterals announced that the Annual General Meeting (AGM) of the company will be ...

Read more

12 Jun 2024 10:01

SMS Pharmaceuticals Ltd News Hub

News

Board of SMS Pharmaceuticals recommends final dividend

SMS Pharmaceuticals announced that the Board of Directors of the Company at its meeting he...

Read more

31 May 2025 14:45

News

SMS Pharmaceuticals to announce Quarterly Result

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May...

Read more

24 May 2025 18:31

News

SMS Pharmaceuticals' Unit VII receives WHO Geneva prequalification

SMS Pharmaceuticals announced that Unit VII manufacturing facility in Visakhapatnam, Andhr...

Read more

02 May 2025 12:36

News

SMS Pharma gains after Hyderabad facility completes USFDA inspection

According to an exchange filing, the inspection was conducted from 17 March to 21 March 20...

Read more

24 Mar 2025 09:59

News

SMS Pharma's Hyderabad facility completes USFDA inspection with 1 observation

According to an exchange filing, the inspection was conducted from 17 March to 21 March 20...

Read more

22 Mar 2025 16:28

News

SMS Pharmaceuticals schedules board meeting

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 Feb...

Read more

06 Feb 2025 16:50

SWOT Analysis Of Bharat Parenterals Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of SMS Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

2

T

BlinkX Score for Bharat Parenterals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for SMS Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Bharat Parenterals Ltd and SMS Pharmaceuticals Ltd

Which company has a larger market capitalization, Bharat Parenterals Ltd or SMS Pharmaceuticals Ltd?

Market cap of Bharat Parenterals Ltd is 892 Cr while Market cap of SMS Pharmaceuticals Ltd is 2,250 Cr

What are the key factors driving the stock performance of Bharat Parenterals Ltd and SMS Pharmaceuticals Ltd?

The stock performance of Bharat Parenterals Ltd and SMS Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bharat Parenterals Ltd and SMS Pharmaceuticals Ltd?

As of June 4, 2025, the Bharat Parenterals Ltd stock price is INR ₹1294.6. On the other hand, SMS Pharmaceuticals Ltd stock price is INR ₹253.9.

How do dividend payouts of Bharat Parenterals Ltd and SMS Pharmaceuticals Ltd compare?

To compare the dividend payouts of Bharat Parenterals Ltd and SMS Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions